See below for the full list of every health and women's health stock in Carbon Collective's Climate Index.

Securing women's right to family planning can reduce overall carbon footprint.

Some 225 million women in lower-income countries say they want the ability to choose whether and when to become pregnant but don't have access to contraception. The result? Some 75 million unintended pregnancies each year. 

Many women in high-income countries don't have access to contraceptives, either. 45% of pregnancies are unintended in the United States, for example. Securing the right to voluntary, high-quality family planning services around the world would have significant positive impacts on the health, welfare, and life expectancy of both women and their children. 

Every person on Earth consumes resources and causes emissions throughout their lifetime. If family planning services are made widely available worldwide and if every boy and girl in the world are given equal quality education, the reduced population size could avoid 85.42 gigatons of CO2 equivalent from 2020 and 2050.

 

It's not about government control over reproduction. It's about women's right to choose.

The topic of limiting population growth is not often discussed because it invokes fears about coercive or cruel efforts by centralized governments to force the birth rate down (or up). 

But this Drawdown solution is the polar opposite. It's about giving women the right to choose whether or not to have children and to plan her future. The right to family planning - through education about sex and reproduction, easy access to contraception, and accommodating social and religious norms about birth control - can meet women's expressed needs, empowerment, equality, and well-being. Benefits to the environment and climate are welcome side effects.

That said, challenges to expanding access to family planning do exist. Many communities don't have basic supply of affordable and culturally appropriate contraception. Education about sex and reproduction isn't available. Health clinics are sparse. 

Currently, the world is $5.3 billion short in funding access to reproductive healthcare that women say they want to have.

Companies can help fill this gap.

The women's health stocks in the Climate Index can help fill this gap. If at least 50% of a company's revenue comes from contraceptive products, they make it into the Index. And as always, we exclude penny stocks whose share prices were less than $0.50 in our last update.

If you are a Carbon Collective member, you own all of these companies through the Climate Index.

Clean Energy Stocks in the Climate Index

Filters:
Index Status:
% ALLOCATED icon Company Type icon Company icon Category icon DESCRIPTION 
-
Contraceptives
Abbvie
Failed Contraceptive Filter
Abbvie makes less than 50% of its revenue from contraceptives, thus failing the contraceptives filter.
0.02%
Pure Play
Agile makes 100% of its revenue from selling a prescription combination hormonal contraceptive patch.
-
Contraceptives
Church & Dwight
Failed Contraceptive Filter
Church & Dwight owns Trojan condoms, but makes less than 50% of its revenue from them, thus failing to pass the contraception filter.
0.02%
Pure Play
Evofem makes 100% of it's revenue from a contraceptive gel. They are also working on a vaginal gel that reduces certain infections.
-
Contraceptives
Merck & Co
Failed Contraceptive Filter
Merck sells prescription medicines, vaccines, animal health products, and more and makes less than 50% of its revenue from contraceptives
-
Contraceptives
ObsEva SA
No Drawdown Solution
ObsEva makes health and pregnacy-related products, but not contraceptives, meaning it does make a Drawdown solution
-
Contraceptives
Pfizer
Lacks Sufficient Information
It is unclear what the revenue breakdown of Pfizer's contraceptive and non-contraceptive products is.
-
Contraceptives
Teva Pharmaceutical Industries
Lacks Sufficient Information
It is unclear what the revenue breakdown of Teva's contraceptive and non-contraceptive products is.
-
Contraceptives
The Cooper Companies
Failed Contraceptive Filter
Cooper sells healthcare products like contact lenses, fertility products, and contraceptives, but makes less than 50% of its revenue from contraceptives
-
Contraceptives
TherapeuticsmMD
Lacks Sufficient Information
It is unclear what the revenue breakdown of TherapeuticsmMD's contraceptive and non-contraceptive products is.
0.03%
Passed Contraceptive Filter
Veru makes more than 50% of its revenue from selling contraceptives and also develops medicines related to prostate and breast cancer.
Abbvie makes less than 50% of its revenue from contraceptives, thus failing the contraceptives filter.
Failed Contraceptive Filter
Agile makes 100% of its revenue from selling a prescription combination hormonal contraceptive patch.
Pure Play
Church & Dwight owns Trojan condoms, but makes less than 50% of its revenue from them, thus failing to pass the contraception filter.
Failed Contraceptive Filter
Evofem makes 100% of it's revenue from a contraceptive gel. They are also working on a vaginal gel that reduces certain infections.
Pure Play
Merck sells prescription medicines, vaccines, animal health products, and more and makes less than 50% of its revenue from contraceptives
Failed Contraceptive Filter
ObsEva makes health and pregnacy-related products, but not contraceptives, meaning it does make a Drawdown solution
No Drawdown Solution
It is unclear what the revenue breakdown of Pfizer's contraceptive and non-contraceptive products is.
Lacks Sufficient Information
It is unclear what the revenue breakdown of Teva's contraceptive and non-contraceptive products is.
Lacks Sufficient Information
Cooper sells healthcare products like contact lenses, fertility products, and contraceptives, but makes less than 50% of its revenue from contraceptives
Failed Contraceptive Filter
It is unclear what the revenue breakdown of TherapeuticsmMD's contraceptive and non-contraceptive products is.
Lacks Sufficient Information
Veru makes more than 50% of its revenue from selling contraceptives and also develops medicines related to prostate and breast cancer.
Passed Contraceptive Filter
Failed Contraceptive Filter
Abbvie makes less than 50% of its revenue from contraceptives, thus failing the contraceptives filter.
Pure Play
Agile makes 100% of its revenue from selling a prescription combination hormonal contraceptive patch.
Failed Contraceptive Filter
Church & Dwight owns Trojan condoms, but makes less than 50% of its revenue from them, thus failing to pass the contraception filter.
Pure Play
Evofem makes 100% of it's revenue from a contraceptive gel. They are also working on a vaginal gel that reduces certain infections.
Failed Contraceptive Filter
Merck sells prescription medicines, vaccines, animal health products, and more and makes less than 50% of its revenue from contraceptives
No Drawdown Solution
ObsEva makes health and pregnacy-related products, but not contraceptives, meaning it does make a Drawdown solution
Lacks Sufficient Information
It is unclear what the revenue breakdown of Pfizer's contraceptive and non-contraceptive products is.
Lacks Sufficient Information
It is unclear what the revenue breakdown of Teva's contraceptive and non-contraceptive products is.
Failed Contraceptive Filter
Cooper sells healthcare products like contact lenses, fertility products, and contraceptives, but makes less than 50% of its revenue from contraceptives
Lacks Sufficient Information
It is unclear what the revenue breakdown of TherapeuticsmMD's contraceptive and non-contraceptive products is.
Passed Contraceptive Filter
Veru makes more than 50% of its revenue from selling contraceptives and also develops medicines related to prostate and breast cancer.
Attend Our Next Webinar

Attend Our Next Webinar

Join our next Sustainable Investing 101 webinar, get our favorite DIY options, and walk through how we build our portfolios.

Register
Get Our Newsletter

Get Our Newsletter

Go a level deeper with us and investigate the potential impacts of climate change on investments like your retirement account.

Join Newsletter
Talk To A Human

Talk To A Human

Joining a new investment service can be intimidating. We’re here for you. Click below to email us a question or book a quick call.

Ask a Question